Literature DB >> 21538985

Discrete-time semi-Markov modeling of human papillomavirus persistence.

C E Mitchell1, M G Hudgens, C C King, S Cu-Uvin, Y Lo, A Rompalo, J Sobel, J S Smith.   

Abstract

Multi-state modeling is often employed to describe the progression of a disease process. In epidemiological studies of certain diseases, the disease state is typically only observed at periodic clinical visits, producing incomplete longitudinal data. In this paper we consider fitting semi-Markov models to estimate the persistence of human papillomavirus (HPV) type-specific infection in studies where the status of HPV type(s) is assessed periodically. Simulation study results are presented indicating that the semi-Markov estimator is more accurate than an estimator currently used in the HPV literature. The methods are illustrated using data from the HIV Epidemiology Research Study.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21538985      PMCID: PMC3129469          DOI: 10.1002/sim.4257

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  18 in total

1.  A queueing model for chronic recurrent conditions under panel observation.

Authors:  Catherine M Crespi; William G Cumberland; Sally Blower
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

2.  Statistical methods for panel data from a semi-Markov process, with application to HPV.

Authors:  Minhee Kang; Stephen W Lagakos
Journal:  Biostatistics       Date:  2006-06-01       Impact factor: 5.899

3.  Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus.

Authors:  Jill E Koshiol; Jane C Schroeder; Denise J Jamieson; Stephen W Marshall; Ann Duerr; Charles M Heilig; Keerti V Shah; Robert S Klein; Susan Cu-Uvin; Paula Schuman; David Celentano; Jennifer S Smith
Journal:  Int J Cancer       Date:  2006-10-01       Impact factor: 7.396

4.  Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women.

Authors:  Jill Koshiol; Jane Schroeder; Denise J Jamieson; Stephen W Marshall; Ann Duerr; Charles M Heilig; Keerti V Shah; Robert S Klein; Susan Cu-Uvin; Paula Schuman; David Celentano; Jennifer S Smith
Journal:  Am J Epidemiol       Date:  2006-06-14       Impact factor: 4.897

5.  Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.

Authors:  K L Liaw; A G Glass; M M Manos; C E Greer; D R Scott; M Sherman; R D Burk; R J Kurman; S Wacholder; B B Rush; D M Cadell; P Lawler; D Tabor; M Schiffman
Journal:  J Natl Cancer Inst       Date:  1999-06-02       Impact factor: 13.506

6.  Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease.

Authors:  R C Gentleman; J F Lawless; J C Lindsey; P Yan
Journal:  Stat Med       Date:  1994-04-30       Impact factor: 2.373

7.  Estimation of parasitic infection dynamics when detectability is imperfect.

Authors:  N J Nagelkerke; R N Chunge; S N Kinoti
Journal:  Stat Med       Date:  1990-10       Impact factor: 2.373

Review 8.  The natural history of cervical HPV infection: unresolved issues.

Authors:  Ciaran B J Woodman; Stuart I Collins; Lawrence S Young
Journal:  Nat Rev Cancer       Date:  2007-01       Impact factor: 60.716

9.  A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.

Authors:  Martyn Plummer; Mark Schiffman; Philip E Castle; Delphine Maucort-Boulch; Cosette M Wheeler
Journal:  J Infect Dis       Date:  2007-04-16       Impact factor: 5.226

10.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis.

Authors:  G M Clifford; J S Smith; M Plummer; N Muñoz; S Franceschi
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

View more
  3 in total

1.  A joint model of persistent human papillomavirus infection and cervical cancer risk: Implications for cervical cancer screening.

Authors:  Hormuzd A Katki; Li C Cheung; Barbara Fetterman; Philip E Castle; Rajeshwari Sundaram
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2015-03-17       Impact factor: 2.483

2.  Analysis of longitudinal multivariate outcome data from couples cohort studies: application to HPV transmission dynamics.

Authors:  Xiangrong Kong; Mei-Cheng Wang; Ronald Gray
Journal:  J Am Stat Assoc       Date:  2015-06-01       Impact factor: 5.033

3.  Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer.

Authors:  S L Sudenga; S Shrestha
Journal:  Int J Infect Dis       Date:  2013-02-27       Impact factor: 3.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.